<ul><li>Passkey Therapeutics, led by CEO Bruce Beutel, aims to develop multi-functional drugs that embrace biological complexity.</li><li>Passkey's platform has applications in cancer, autoimmune diseases, neurodegenerative disorders, and metabolic diseases.</li><li>Passkey utilizes advanced computational tools to identify multilogs and target complex diseases effectively.</li><li>With investments from Breakout Ventures, Innovation Endeavors, and Bison Ventures, Passkey is well-positioned for success in the new era of drug discovery.</li></ul>

Passkey Therapeutics: Unlocking Multi-functional Drugs

Discover more